U.K. Erectile Dysfunction Market - Industry Trends and Forecast to 2031
U.K. erectile dysfunction market is expected to reach USD 451.63 million by 2031, from USD 260.49 thousand in 2023 growing at the CAGR of 7.2% in the forecast period of 2024 to 2031.
Market Segmentation
U.K. Erectile Dysfunction Market, By Product Type (Drugs and Devices), Type (Secondary Erectile Dysfunction and Primary Erectile Dysfunction), Age Group (Less than 40, 40-60 and 60 - Above), End User (Hospital, Specialty Clinics, Home Healthcare, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tenders, Retail Pharmacy, Online Pharmacy, Hospital Pharmacy and Others) - Industry Trends and Forecast to 2031
Overview of U.K. Erectile Dysfunction Market Dynamics
Driver
• Rising prevalence of chronic diseases
Restraint
• Regulatory constraints for approval
Opportunity
• Availability of prescription medication and its generic version
Market Players
Some of the key market players for U.K. erectile dysfunction market are:
• Lupin
• Teva Pharmaceutical Industries Ltd.
• Augusta Medical Systems
• Boston Scientific Corporation
• Coloplast Corp
• Rigicon, Inc.
• Pfizer Inc.
• Bayer AG
• Eli Lily and Company
• Viatris Inc.
• ZSI, Zephyr Surgical Implants
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of U.K. Erectile Dysfunction Market
- 1.4 Currency And Pricing
- 1.5 Limitations
- 1.6 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Dbmr Tripod Data Validation Model
- 2.5 Primary Interviews With Key Opinion Leaders
- 2.6 Multivariate Modelling
- 2.7 Market End User Coverage Grid
- 2.8 Product Lifeline Curve
- 2.9 Dbmr Market Position Grid
- 2.10 Vendor Share Analysis
- 2.11 Secondary Sources
- 2.12 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Pestel Analysis
- 4.2 Porter's Five Forces Model
- 4.3 Vendor Share Analysis
- 4.4 Brand Analysis
- 4.4.1 Leading Brands
- 4.4.2 Brand Positioning
- 4.4.3 Market Penetration
- 4.4.4 Competitive Analysis
- 4.5 Consumer Insights
- 4.5.1 Demographic Insights
- 4.5.2 Psychographic Profile
- 4.5.3 Consumer Preferences
- 4.5.4 Purchasing Behaviour
- 4.5.5 Factors Influencing Buying Decision
- 4.6 Performance Analysis
- 4.6.1 Trend Analysis
- 4.7 Retail Analysis
- 5 Market Overview
- 5.1 Drivers
- 5.1.1 Rising Prevalence Of Chronic Diseases
- 5.1.2 Rising Adoption Of Sedentary Lifestyle And Associated Stress
- 5.1.3 Rising Product Launches By Major Market Players
- 5.1.4 Rising Patient Awareness Regarding The Condition And Medication
- 5.2 Restraints
- 5.2.1 Regulatory Constraints For Approval
- 5.2.2 High Cost Of Erectile Dysfunction Treatment
- 5.3 Opportunities
- 5.3.1 Availability Of Prescription Medication And Its Generic Version
- 5.3.2 Rising Technological Advancements
- 5.3.3 Rising Research And Development Activities
- 5.4 Challenges
- 5.4.1 Various Side Effects Associated With Erectile Dysfunction Drugs
- 5.4.2 Lack Of Skilled Professionals
- 6 U.K. Erectile Dysfunction Market, By Product Type
- 6.1 Overview
- 6.2 Drugs
- 6.2.1 Oral Drugs
- 6.2.1.1 Branded
- 6.2.1.1.1 Viagra
- 6.2.1.1.2 Cialis
- 6.2.1.1.3 Levitra
- 6.2.1.1.4 Avanafil
- 6.2.1.1.5 Others
- 6.2.1.2 Generic
- 6.2.2 Topical Formulation
- 6.2.3 Penile Injections
- 6.2.3.1 Papaverine
- 6.2.3.2 Phentolamine
- 6.2.3.3 Prostaglandin E1 (Pge1)
- 6.2.4 Suppositories
- 6.3 Devices
- 6.3.1 Penis Pumps/Vaccum Constriction Devices
- 6.3.1.1 Hand-powered
- 6.3.1.2 Battery-powered Pump
- 6.3.2 Penile Implants
- 6.3.2.1 Semirigid/Malleable
- 6.3.2.2 Inflatable
- 6.3.3 Shock Wave Therapy
- 7 U.K. Erectile Dysfunction Market, By Type
- 7.1 Overview
- 7.2 Secondary Erectile Dysfunction
- 7.3 Primary Erectile Dysfunction
- 8 U.K. Erectile Dysfunction Market, By Age Group
- 8.1 Overview
- 8.2 Less Than 40
- 8.3 40-60
- 8.4 60 And Above
- 9 U.K. Erectile Dysfunction Market, By End User
- 9.1 Overview
- 9.2 Hospitals
- 9.3 Specialty Clinics
- 9.4 Home Healthcare
- 9.5 Ambulatory Surgical Centers
- 9.6 Others
- 10 U.K. Erectile Dysfunction Market, By Distribution Channel
- 10.1 Overview
- 10.2 Direct Tenders
- 10.3 Hospital Pharmacy
- 10.4 Retail Pharmacy
- 10.5 Online Pharmacy
- 10.6 Others
- 11 U.K. Erectile Dysfunction Market, Company Landscape
- 11.1 Company Share Analysis: Global
- 12 Swot Analysis
- 13 Company Profiles
- 13.1 Pfizer Inc.
- 13.1.1 Company Snapshot
- 13.1.2 Revenue Analysis
- 13.1.3 Product Portfolio
- 13.1.4 Recent Developments
- 13.2 Lupin
- 13.2.1 Company Snapshot
- 13.2.2 Revenue Analysis
- 13.2.3 Product Portfolio
- 13.2.4 Recent Developments
- 13.3 Coloplast Corp
- 13.3.1 Company Snapshot
- 13.3.2 Revenue Analysis
- 13.3.3 Product Portfolio
- 13.3.4 Recent Developments
- 13.4 Viatris Inc.
- 13.4.1 Company Snapshot
- 13.4.2 Revenue Analysis
- 13.4.3 Product Portfolio
- 13.4.4 Recent Developments
- 13.5 Teva Pharmaceutical Industries Ltd.
- 13.5.1 Company Snapshot
- 13.5.2 Revenue Analysis
- 13.5.3 Product Portfolio
- 13.5.4 Recent Developments
- 13.6 Augusta Medical Systems
- 13.6.1 Company Snapshot
- 13.6.2 Product Portfolio
- 13.6.3 Recent Development
- 13.7 Bayer Ag
- 13.7.1 Company Snapshot
- 13.7.2 Revenue Analysis
- 13.7.3 Product Portfolio
- 13.7.4 Recent Developments
- 13.8 Boston Scientific Corporation
- 13.8.1 Company Snapshot
- 13.8.2 Revenue Analysis
- 13.8.3 Product Portfolio
- 13.8.4 Recent Developments
- 13.9 Eli Lily And Company
- 13.9.1 Company Snapshot
- 13.9.2 Revenue Analysis
- 13.9.3 Product Portfolio
- 13.9.4 Recent Developments
- 13.10 Rigicon, Inc.
- 13.10.1 Company Snapshot
- 13.10.2 Product Portfolio
- 13.10.3 Recent Development
- 13.11 Zephyr Surgical Implants.
- 13.11.1 Company Snapshot
- 13.11.2 Product Portfolio
- 13.11.3 Recent Development
- 14 Questionnaire
- 15 Related Reports
- List Of Tables
- Table 1 U.K. Erectile Dysfunction Market, By Product Type, 2022-2031 (Usd Million)
- Table 2 U.K. Drugs In Erectile Dysfunction Market, By Type, 2022-2031 (Usd Million)
- Table 3 U.K. Oral Drugs In Erectile Dysfunction Market, By Type, 2022-2031 (Usd Million)
- Table 4 U.K. Branded In Erectile Dysfunction Market, By Type, 2022-2031 (Usd Million)
- Table 5 U.K. Penile Injections In Erectile Dysfunction Market, By Type, 2022-2031 (Usd Million)
- Table 6 U.K. Devices In Erectile Dysfunction Market, By Type, 2022-2031 (Usd Million)
- Table 7 U.K. Penis Pumps/Vaccum Constriction Devices In Erectile Dysfunction Market, By Type, 2022-2031 (Usd Million)
- Table 8 U.K. Penile Implants In Erectile Dysfunction Market, By Type, 2022-2031 (Usd Million)
- Table 9 U.K. Erectile Dysfunction Market, By Type, 2022-2031 (Usd Million)
- Table 10 U.K. Erectile Dysfunction Market, By Age Group, 2022-2031 (Usd Million)
- Table 11 U.K. Erectile Dysfunction Market, By End User, 2022-2031 (Usd Million)
- Table 12 U.K. Erectile Dysfunction Market, By Distribution Channel, 2022-2031 (Usd Million)
- List Of Figures
- Figure 1 U.K. Erectile Dysfunction Market: Segmentation
- Figure 2 U.K. Erectile Dysfunction Market: Data Triangulation
- Figure 3 U.K. Erectile Dysfunction Market: Droc Analysis
- Figure 4 U.K. Erectile Dysfunction Market: Regional Vs Country Market Analysis
- Figure 5 U.K. Erectile Dysfunction Market: Company Research Analysis
- Figure 6 U.K. Erectile Dysfunction Market: Interview Demographics
- Figure 7 U.K. Erectile Dysfunction Market: Market End User Coverage Grid
- Figure 8 U.K. Erectile Dysfunction Market: Dbmr Market Position Grid
- Figure 9 U.K. Erectile Dysfunction Market: Vendor Share Analysis
- Figure 10 U.K. Erectile Dysfunction Market: Segmentation
- Figure 11 The Rising Rates Of Chronic Diseases Among Men Is Expected To Drive The Growth Of The U.K. Erectile Dysfunction Market From 2024 To 2031
- Figure 12 The Drugs Segment Is Expected To Account For The Largest Share Of The U.K. Erectile Dysfunction Market In 2024 And 2031
- Figure 13 Drivers, Restraints, Opportunities, And Challenges Of U.K Erectile Dysfunction Market
- Figure 14 U.K. Erectile Dysfunction Market: By Product Type, 2022
- Figure 15 U.K. Erectile Dysfunction Market: By Product Type, 2024-2031 (Usd Million)
- Figure 16 U.K. Erectile Dysfunction Market: By Product Type, Cagr (2024-2031)
- Figure 17 U.K. Erectile Dysfunction Market: By Product Type, Lifeline Curve
- Figure 18 U.K. Erectile Dysfunction Market: By Type, 2022
- Figure 19 U.K. Erectile Dysfunction Market: By Type, 2024-2031 (Usd Million)
- Figure 20 U.K. Erectile Dysfunction Market: By Type, Cagr (2024-2031)
- Figure 21 U.K. Erectile Dysfunction Market: By Type, Lifeline Curve
- Figure 22 U.K. Erectile Dysfunction Market: By Age Group, 2022
- Figure 23 U.K. Erectile Dysfunction Market: By Age Group, 2024-2031 (Usd Million)
- Figure 24 U.K. Erectile Dysfunction Market: By Age Group, Cagr (2024-2031)
- Figure 25 U.K. Erectile Dysfunction Market: By Age Group, Lifeline Curve
- Figure 26 U.K. Erectile Dysfunction Market: By End User, 2023
- Figure 27 U.K. Erectile Dysfunction Market: By End User, 2024-2031 (Usd Million)
- Figure 28 U.K. Erectile Dysfunction Market: By End User, Cagr (2024-2031)
- Figure 29 U.K. Erectile Dysfunction Market: By End User, Lifeline Curve
- Figure 30 U.K. Erectile Dysfunction Market: By Distribution Channel, 2022
- Figure 31 U.K. Erectile Dysfunction Market: By Distribution Channel, 2024-2031 (Usd Million)
- Figure 32 U.K. Erectile Dysfunction Market: By Distribution Channel, Cagr (2024-2031)
- Figure 33 U.K. Erectile Dysfunction Market: By Distribution Channel, Lifeline Curve
- Figure 34 U.K. Erectile Dysfunction Market: Company Share 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook